๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Radiation therapy following radical prostatectomy

โœ Scribed by W. Robert Lee; Gerald E. Hanks


Publisher
John Wiley and Sons
Year
1995
Tongue
English
Weight
522 KB
Volume
75
Category
Article
ISSN
0008-543X

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Effect of adjuvant radiation therapy on
โœ Joseph C. Presti Jr.; Mack Roach III; Perinchery A. Narayan; Christopher J. Kane ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 361 KB ๐Ÿ‘ 1 views

The object of this study was to evaluate the impact of adjuvant radiation therapy (RT) following radical prostatectomy on urodynamic parameters. Urodynamic evaluation was performed on 10 men who underwent adjuvant RT following radical prostatectomy (study group; 4 studied both before and after) and

Delayed/salvage radiation therapy in pat
โœ Eitan Medini; Iris Medini; Pratap K. Reddy; Seymour H. Levitt ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 507 KB

## BACKGROUND. In this article the authors report an analysis and long term results of delayedlsalvage radiation therapy administered to asymptomatic patients who had an elevated prostate specific antigen (PSA) level, many months to many years after radical prostatectomy. ## METHODS. During 198

Postoperative radiation therapy after ra
โœ Robert Meier; Rufus Mark; Leslie St. Royal; Luu Tran; Gregory Colburn; Robert Pa ๐Ÿ“‚ Article ๐Ÿ“… 1992 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 589 KB

## Background: The role and benefit of adjuvant radiation therapy after radical prostatectomy is unclear. this role was evaluated in 58 patients who, after undergoing radical prostatectomy for prostate carcinoma, had local extension of disease beyond the prostate or positive surgical margins. thirt

Utilization and expense of adjuvant canc
โœ Benjamin Spencer ๐Ÿ“‚ Article ๐Ÿ“… 2011 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 67 KB

Several randomized trials and a treatment guideline favor the use of adjuvant therapy for patients with adverse pathological features identified at radical prostatectomy. This study describes the variation in patterns of utilization and costs associated with these therapies.